Qingqing Mo
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Mitochondrial Function and Pathology
Papers in
-
- Ubiquitin and proteasome pathways 3
- Histone Deacetylase Inhibitors Research 2
- Epigenetics and DNA Methylation 2
- Oncology 4
- Cancer-related Molecular Pathways 2
- Co-authors
- Pingbo Chen (9 shared papers)Ding Ma (7 shared papers)Qinglei Gao (5 shared papers)Beibei Wang (5 shared papers)Xin Jin (5 shared papers)Peng Wu (3 shared papers)Yong Fang (4 shared papers)Yue Gao (4 shared papers)
In The Last Decade
Qingqing Mo
11 papers receiving 174 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 57
- Molecular Biology 125
- Cell Biology 28
- Oncology 40
- Toxicology 4
Countries citing papers authored by Qingqing Mo
This map shows the geographic impact of Qingqing Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqing Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqing Mo more than expected).
Fields of papers citing papers by Qingqing Mo
This network shows the impact of papers produced by Qingqing Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqing Mo. The network helps show where Qingqing Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingqing Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 44 | |
| 2 | 2016 | 36 | |
| 3 | 2017 | 17 | |
| 4 | 2013 | 16 | |
| 5 | 2013 | 15 | |
| 6 | 2016 | 14 | |
| 7 | 2019 | 13 | |
| 8 | 2012 | 7 | |
| 9 | 2019 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2014 | 4 | |
| 12 | 2024 | 0 |
About Qingqing Mo
Qingqing Mo is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Genetics, having authored 12 papers that have together received 175 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Microtubule and mitosis dynamics (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer-related Molecular Pathways (2 papers), Epigenetics and DNA Methylation (2 papers), Glioma Diagnosis and Treatment (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (57 citations), Molecular Biology (125 citations), Cell Biology (28 citations), Oncology (40 citations) and Toxicology (4 citations). Qingqing Mo has collaborated with scholars based in China, Spain and Hong Kong. Frequent co-authors include Pingbo Chen, Ding Ma, Qinglei Gao, Beibei Wang, Xin Jin, Peng Wu, Yong Fang, Yue Gao, Jianfeng Zhou and Yuan Wu. Their work appears in journals such as EBioMedicine, Cancer Biology & Therapy, Oncology Reports, Cell Death and Disease and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.